AthanassiosArgirisMD

Clinical Trials

• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx Start of enrollment: 1999 Aug 01

  Unknown status

  Phase 2

• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer Start of enrollment: 1999 Aug 01

  Unknown status

  Phase 1

• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer Start of enrollment: 2002 Nov 19

  Completed

  Phase 2

• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer Start of enrollment: 2002 Sep 01

  Completed

  Phase 2

• Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2003 May 01

  Terminated

  Phase 2

• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2003 Jun 01

  Completed

  Phase 1, Phase 2

• Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck Start of enrollment: 2004 Jun 01

  Completed

  Phase 2

• Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer Start of enrollment: 2004 Aug 01

  Terminated

  Phase 3

• Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23

  Active, not recruiting

  Phase 1, Phase 2

• Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2006 Oct 01
• Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2007 Jun 01

  Withdrawn

  Phase 2

• Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC Start of enrollment: 2006 Jun 01

  Completed

  Phase 2

• Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck Start of enrollment: 2007 Nov 01

  Completed

  Phase 2

• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08

  Active, not recruiting

  Phase 3

• Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2010 Mar 01

  Terminated

  Phase 2

• Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301 Start of enrollment: 2011 Dec 22

  Completed

• Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies Start of enrollment: 2012 Jul 01

  Withdrawn

  Phase 2

• Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients Start of enrollment: 2013 Oct 01

  Terminated

  Phase 1

• Join now to see all